摘要
Pancreatic ductal adenocarcinoma(PDAC)remains the most lethal type of cancer.The 5-year survival rate for patients with early-stage diagnosis can be as high as 20%,suggesting that early diagnosis plays a pivotal role in the prognostic improvement of PDAC cases.In the medical field,the broad availability of biomedical data has led to the advent of the“big data”era.To overcome this deadly disease,how to fully exploit big data is a new challenge in the era of precision medicine.Artificial intelligence(AI)is the ability of a machine to learn and display intelligence to solve problems.AI can help to transform big data into clinically actionable insights more efficiently,reduce inevitable errors to improve diagnostic accuracy,and make real-time predictions.AI-based omics analyses will become the next alterative approach to overcome this poor-prognostic disease by discovering biomarkers for early detection,providing molecular/genomic subtyping,offering treatment guidance,and predicting recurrence and survival.Advances in AI may therefore improve PDAC survival outcomes in the near future.The present review mainly focuses on recent advances of AI in PDAC for clinicians.We believe that breakthroughs will soon emerge to fight this deadly disease using AI-navigated precision medicine.
